CME Group Inc.
BG ˙ BUL ˙ US12572Q1058
SecurityBG:MX4A / CME Group Inc.
InstitutionFirst National Advisers, LLC
Latest Disclosed Ownership12,787 shares
Latest Disclosed Value $ 3,776,351
First National Advisers, LLC reports 13.44% decrease in ownership of MX4A / CME Group Inc.

On May 8, 2026 - First National Advisers, LLC filed a 13F-HR form disclosing ownership of 12,787 shares of CME Group Inc. (BG:MX4A) valued at $3,776,351 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 4, 2026 disclosing 14,773 shares of CME Group Inc.. This represents a change in shares of -13.44% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-08 2026-03-31 13F CME GROUP COM 12572Q105 12,787 -1,986 -13.44 3,776 -6.40 0.5525
2026-02-04 2025-12-31 13F CME GROUP COM 12572Q105 14,773 -277 -1.84 4,035 -0.76 0.5548
2025-10-28 2025-09-30 13F CME GROUP COM 12572Q105 15,050 373 2.54 4,066 0.49 0.5517
2025-08-13 2025-06-30 13F CME GROUP COM 12572Q105 14,677 14 0.10 4,046 4.01 0.5924
2025-05-07 2025-03-31 13F CME GROUP COM 12572Q105 14,663 -206 -1.39 3,890 12.66 0.6226
2025-02-10 2024-12-31 13F CME GROUP COM 12572Q105 14,869 -2,271 -13.25 3,453 -8.73 0.5583
2024-10-15 2024-09-30 13F CME GROUP COM 12572Q105 17,140 616 3.73 3,783 16.44 0.6032
2024-08-13 2024-06-30 13F CME GROUP COM 12572Q105 16,524 2,240 15.68 3,249 9.77 0.5937
2024-05-15 2024-03-31 13F CME GROUP COM 12572Q105 14,284 1,834 14.73 2,960 12.85 0.6623
2024-02-08 2023-12-31 13F CME GROUP COM 12572Q105 12,450 3,749 43.09 2,622 50.52 0.7548
2023-11-09 2023-09-30 13F CME GROUP COM 12572Q105 8,701 3,779 76.78 1,742 91.01 0.7780
2023-08-11 2023-06-30 13F CME GROUP COM 12572Q105 4,922 57 1.17 912 -2.15 0.8400
2023-05-10 2023-03-31 13F CME GROUP COM 12572Q105 4,865 426 9.60 932 24.77 1.0569
2023-02-09 2022-12-31 13F CME GROUP COM 12572Q105 4,439 1,955 78.70 747 69.77 0.9562
2022-11-07 2022-09-30 13F CME GROUP COM 12572Q105 2,484 712 40.18 440 21.21 0.6519
2022-08-12 2022-06-30 13F CME GROUP COM 12572Q105 1,772 1,772 363 0.7533
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.